Hosted on MSN

FDA clears Cepheid’s Xpert GI panel for pathogen detection

Cepheid has received clearance from the US Food and Drug Administration (FDA) for its Xpert GI Panel, a multiplex polymerase chain reaction (PCR) gastrointestinal (GI) pathogen testing solution. The ...
Nature

Multiplex Molecular Diagnostics for Gastrointestinal Pathogens

Multiplex molecular diagnostics encompass high‐throughput assays capable of detecting a wide array of gastrointestinal pathogens—bacterial, viral and parasitic—in a single test run. By integrating ...
Nasdaq

Cepheid Receives CE Marking Under IVDR for Xpert® GI Panel

SUNNYVALE, Calif., May 13, 2026 /PRNewswire/ -- Cepheid, a Danaher company, announced today that it has received CE marking under the in vitro medical device regulation (IVDR) for the Xpert GI Panel.
Healio

FDA-cleared GI test detects ‘most likely causes’ of diarrheal syndromes

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The test aids in detecting eight bacteria, two parasites ...
Business Wire

Applied BioCode Announces New Nucleic Acid Extraction Claim for KingFisher™ Flex Nucleic Acid Purification System with BioCode® Gastrointestinal Pathogen Panel (GPP)

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, a leader in molecular diagnostics panel testing, is excited to announce a significant enhancement to its BioCode ® Gastrointestinal Pathogen ...